Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PGFW | ISIN: CNE100003F01 | Ticker-Symbol: CJH
Frankfurt
27.06.25 | 15:29
3,680 Euro
-0,54 % -0,020
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
CANSINO BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
CANSINO BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,6743,77227.06.
3,6503,77027.06.

Aktuelle News zur CANSINO BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CANSINO BIOLOGICS Aktie jetzt für 0€ handeln
20.06.CanSino Biologics Inc: CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health257HONG KONG, June 20, 2025 - (ACN Newswire) - Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single...
► Artikel lesen
20.06.CANSINOBIO (06185): INSIDE INFORMATION - NMPA OF CHINA GRANTS NDA APPROVAL TO PCV13I5
04.06.CANSINOBIO (06185): POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING3
15.05.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - INHALED TB BOOSTER OBTAINS CLINICAL TRIAL APPROVAL IN INDONESIA5
13.05.CANSINOBIO (06185): FORM OF PROXY FOR USE AT THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 4, 20252
13.05.CANSINOBIO (06185): NOTICE OF 2024 ANNUAL GENERAL MEETING1
13.05.CANSINOBIO (06185): 2024 AGM CIRCULAR2
29.04.CANSINOBIO (06185): FIRST QUARTERLY REPORT FOR THE THREE MONTHS ENDED MARCH 31, 20254
16.04.CANSINOBIO (06185): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
16.04.CANSINOBIO (06185): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
16.04.CANSINOBIO (06185): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE & CORPORATE SOCIAL RESPONSIBILITY REPORT-
16.04.CANSINOBIO (06185): 2024 ANNUAL REPORT1
15.04.CANSINOBIO (06185): NOTICE OF BOARD MEETING1
25.03.CanSino Biologics Inc: Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong296HONG KONG, Mar 25, 2025 - (ACN Newswire) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant...
► Artikel lesen
25.03.CANSINOBIO (06185): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024-
12.03.CANSINOBIO (06185): NOTICE OF BOARD MEETING4
27.02.CANSINOBIO (06185): INSIDE INFORMATION - UPDATES ON 2024 PRELIMINARY ANNUAL RESULTS4
24.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - DTCP-HIB-MCV4 COMBINED VACCINE OBTAINS CLINICAL TRIAL APPROVAL IN CHINA14
17.02.CanSinoBIO to Showcase China's Vaccine Innovation at 2025 World Government Summit in Dubai345DUBAI, UAE, Feb. 17, 2025 /PRNewswire/ -- CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in...
► Artikel lesen
07.02.CANSINOBIO (06185): VOLUNTARY ANNOUNCEMENT - THE CENTER FOR DRUG EVALUATION, NMPA GRANTED PRIORITY REVIEW STATUS TO NDA FOR DTCP INFANT4
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1